Neuphoria Therapeutics Inc.

NEUP | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.05

-$0.01 (-0.33%)

At close: Oct 30, 2026, 4:00 PM ET

$3.05

$0.00 (0.00%)

After-hours: Oct 30, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $16.5M

Enterprise Value $-3.33M

Beta 0.75

Average Volume 138.04K

Shares Outstanding (Diluted) 5.41M

Shares Change YoY 233.43%

Institutional Ownership 36.85%

Exchange NASDAQ

ISIN US64136E1029

Price Performance

Price Change 1M -14.3%

Price Change 3M -21.4%

Price Change 6M -41.6%

Price Change YTD -21.4%

Price Change 1Y -33.0%

Price Change 3Y -89.7%

Price Change 5Y N/A

1M CAGR (ann.) -17.6%

1Y CAGR (ann.) -33.4%

5Y CAGR (ann.) N/A

All-Time CAGR -56.5%

Valuation

PE Ratio -0.42

Forward PE N/A

PEG Ratio -0.00

Forward PEG 0.01

PS Ratio 14.06

Forward PS 27.10

PB Ratio 0.67

P/FCF Ratio -0.00

P/Adj. FCF Ratio -0.00

P/OCF Ratio -0.00

EV/Sales -2.83

EV/EBIT 0.25

EV/EBITDA 0.26

EV/FCF 0.00

Earnings Yield -238.0%

FCF Yield -74849.6%

Adj. FCF Yield -76979.5%

Financial Health

Net Cash $19.83M

Total Debt $34.35K

Cash & Short-Term Investments $19.87M

Total Assets $28.71M

Current Ratio 27.85

Quick Ratio 27.85

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt -359,691.64

Interest Coverage 0.00

Altman Z-Score -7.59

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 43.5%

Operating Profit Margin -1187.7%

EBITDA Margin -1084.7%

Net Profit Margin -1578.4%

FCF Margin -1052118.7%

Adj. FCF Margin -1082057.4%

SBC / Revenue 29938.7%

SBC Impact (per share) -2.9%

Returns

Return on Assets -64.5%

Return on Equity -77.0%

Return on Invested Capital -49.4%

Return on Capital Employed -49.9%

Return on Tangible Assets -88.0%

Historical Growth (CAGR)

Revenue CAGR 3Y 4086.7%

Revenue CAGR 5Y 4.8%

Revenue CAGR 10Y -24.4%

EPS CAGR 3Y -194.4%

EPS CAGR 5Y -113.3%

EPS CAGR 10Y -56.0%

FCF CAGR 3Y -150.4%

FCF CAGR 5Y -99.6%

FCF CAGR 10Y -54.2%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 1

EPS Growth Next 3Y 10.2%

Revenue Growth Next 3Y 265.4%

Earnings Date Sep 18, 2026

EPS Estimate (next Q) -$0.56

EPS Growth Est (next Q) -90.3%

Revenue Est (next Q) $996.48K

Revenue Growth Est (next Q) -15430.5%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $7.00

Price Target Upside 129.5%

Cash Flow

Operating Cash Flow $-12.35B

Free Cash Flow $-12.35B

Adj. Free Cash Flow $-12.71B

FCF Per Share -$2,282.91

OCF Per Share -$2,282.91

OCF/S Ratio -1052118.7%

Income Statement

Revenue $1.17M

Gross Profit $511.21K

Operating Income $-13.95M

EBITDA $-12.57M

Net Income $-18.53M

EPS (Diluted) -$7.26

Revenue / Employee $1.17M

Profit / Employee $-18.53M

Employees 1